HESPEROS, INC
Orlando, FL · Medtech · Private
Pumpless microphysiological systems with integrated microelectrode arrays for drug toxicity and efficacy testing
hesperosinc.com →- Grants
- $38M
- 38 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $434K
- 4 awards · Health and Human S
- #394 of 4531 in medtech
- Patents
- 5
- 2 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Advanced Human on a Chip Systems for Drug Discovery | $1,241,321 | |
| Federal grant | Department of Health and Human Services · Phase II · Advanced Human on a Chip Systems for Drug Discovery | $735,615 | |
| Federal grant | Department of Health and Human Services · Phase II · Functional integrated human-on-a-chip systems for Alzheimer's research | $454,315 | |
| Federal grant | Department of Health and Human Services · Phase I · Integration of a kidney module into a 4-organ human-on-a-chip system. | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Human on a chip system to investigate genetic risk factors in Alzheimer's disease | $334,005 | |
| Federal grant | Department of Health and Human Services · Phase I · HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform | $224,946 | |
| Federal grant | Department of Health and Human Services · Phase I · Human on a chip system to investigate genetic risk factors in Alzheimer's disease | $669,257 | |
| Federal grant | Department of Health and Human Services · Phase II · Automation and validation of human on a chip systems for drug discovery | $1,363,424 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an integrated 4-organ animal model | $220,124 | |
| Federal grant | Department of Health and Human Services · Phase II · Functional integrated human-on-a-chip systems for Alzheimer's research | $1,507,755 | |
| Federal grant | Department of Health and Human Services · Phase II · Functional integrated human-on-a-chip systems for Alzheimer's research | $3,015,508 | |
| Federal grant | Department of Health and Human Services · Phase II · Automation and validation of human on a chip systems for drug discovery | $186,828 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $224,999 | |
| Federal grant | Department of Health and Human Services · Phase I · Human on a chip system to investigate genetic risk factors in Alzheimer's disease | $335,252 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an integrated 4-organ animal model | $744,745 | |
| Federal contract | Department of Health and Human Services · Hesperos, LLC:1280468 [19-005001] | $100,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Automation and validation of human on a chip systems for drug discovery | $1,412,888 | |
| Federal grant | Department of Health and Human Services · Phase II · Automation and validation of human on a chip systems for drug discovery | $73,535 | |
| Federal grant | Department of Health and Human Services · Phase II · Functional integrated human-on-a-chip systems for Alzheimer's research | $1,507,753 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $1,483,966 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $4,451,898 | |
| Federal contract | Department of Health and Human Services · Gather Remaining Data For Manuscript Submission As Well As Screening Of Drug Compounds To Ameliorate NGLY1 Mediated Disfunction. (phase II); Period Of Performance: July 27, 2020 - March 26, 2021 | $159,282 | |
| Federal grant | Department of Health and Human Services · Phase II · Development of an integrated 4-organ animal model | $744,745 | |
| Federal grant | Department of Health and Human Services · Phase II · Automation and validation of human on a chip systems for drug discovery | $1,404,459 | |
| Federal grant | Department of Health and Human Services · Phase II · Biodistribution and PK modeling of rat vs. human systems | $226,260 | |
| Federal grant | Department of Health and Human Services · Phase II · Biodistribution and PK modeling of rat vs. human systems | $754,240 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $1,483,966 | |
| Federal contract | Department of Health and Human Services · Ncats Project Phase II Supplement - Target Validation And Therapeutic Evaluation In NGLY1DEFICIENT Chip-based Models, Pop: 6/21/2021-10/20/2021 | $142,843 | |
| Federal grant | Department of Health and Human Services · Phase II · Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia | $902,320 | |
| Federal grant | Department of Health and Human Services · Phase II · Hesperos Diversity Supplement forgrant number 1 R44AG071386 | $1,967,361 | |
| Federal grant | Department of Health and Human Services · Phase II · Populating MPS database with data from multi-organ, human-on-a-chip microphysiological systems | $77,997 | |
| Federal grant | Department of Health and Human Services · Phase II · Biodistribution and PK modeling of rat vs. human systems | $789,413 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform | $854,765 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform | $1,709,530 | |
| Federal grant | Department of Health and Human Services · Phase II · Human on a chip systems to investigate disease comorbidities common in the aged population | $1,483,966 | |
| Federal grant | Department of Health and Human Services · Phase II · Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Cholinergic Drug Induced Dementia | $902,299 | |
| Federal grant | Department of Health and Human Services · Phase II · Hesperos Diversity Supplement forgrant number 1 R44AG071386 | $162,742 | |
| Federal grant | Department of Health and Human Services · Phase II · HLS-Development of a cardiac ischemia model in an organ-on-a-chip platform | $854,765 | |
| Federal contract | Department of Health and Human Services · Hesperos, LLC:1280468 [24-000168] | $32,235 | |
| Federal grant | Department of Health and Human Services · Phase II · Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia | $1,500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Modulatory Role of Blood-Brain-Barrier and Enzymatic Activity in an Innovative Human Model of Anticholinergic Drug Induced Dementia | $1,499,996 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 391 | Magnolia Medical Technologies, Inc. | $452K | $87M |
| 392 | NANOVIEW BIOSCIENCES, INC. | $449K | $18M |
| 393 | BENTEN TECHNOLOGIES, INC. | $446K | — |
| 394 | HESPEROS, INC | $434K | — |
| 395 | ZMK Medical Technologies, Inc. | $422K | — |
| 396 | Nanalysis Corp. | $411K | $15K |
| 397 | AMPLIFIDX INC | $400K | $329K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Method And System For Printing Cells To A Substrate Comprising Cell Adhesive Regionsgranted
- Pumpless Microfluidic Organ-on-a-chip System Including A Functional Immune Systemgranted
- Method And System For Printing Cells To A Substrate Comprising Cell Adhesive Regionsapplication
- Pumpless Microfluidic Organ-on-a-chip System Including A Functional Immune Systemapplication
- Pumpless Microfluidic Organ-on-a-chip System Including A Functional Immune Systemapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.